Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 1, 2000, Pages 19-23

  Kuhara, Tetsuya ^a   Uchida, Katsuhisa ^b   Yamaguchi, Hideyo ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; COLONY STIMULATING FACTOR 1; FLUCONAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL KILLING; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; HUMAN; MACROPHAGE ACTIVATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0033988660     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.1.19-23.2000     Document Type: Article

References (37)

1. Abe, S., T. Satoh, Y. Tokuda, S. Tansho, and H. Yamaguchi. 1994. A rapid colorimetric assay for determination of leukocyte-mediated inhibition of mycelial growth of Candida albicans. Microbiol. Immunol. 38:385-388.
2. Aoyagi, K., N. Itoh, F. Abe, S. Abe, K. Uchida, M. Ishizuka, T. Takeuchi, and H. Yamaguchi. 1992. Enhancement by ubenimex (bestain) of host resistance to Candida albicans infection. J. Antibiot. 45:1778-1784.
3. Bodey, G. P. 1992. Azole anti-fungal agents. Clin. Infect. Dis. 14(Suppl. 1):5161-5169.
4. Brummer, E., F. Nassar, and D. A. Stevens. 1994. Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing. Antimicrob. Agents Chemother. 38:2158-2161.
5. Cenci, E., A. Bartocci, P. Puccetti, S. Mocci, E. R. Stanley, and F. Bistoni. 1991. Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infect. Immun. 59:868-872.
6. 3H-glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J. Immunol. Methods 92:73-77.
7. Drummond, D. C., C. W. Wong, L. M. Whitman, and J. G. McCormack. 1995. The effects of amphotericin B, fluconazole and miconazole on neutrophil and lymphocyte function in a guinea pig model. J. Antimicrob. Chemother. 36:375-384.
8. Gelfand, J. A., K. Kimball, J. F. Burke, and C. A. Dinarello. 1988. Amphotericin B treatment of human mononuclear cells in vitro results in secretion of tumor necrosis factor and interleukin-1. Clin. Res. 36:456a.
9. Hashimoto, S., M. Yoda, M. Yamada, N. Yanai, T. Kawashima, and K. Motoyoshi. 1996. Macrophage colony-stimulating factor induces interleukin-8 production in human monocytes. Exp. Hematol. 24:123-128.
10. Hatake, K., K. Motoyoshi, Y. Ishizaka, F. Takaku, and Y. Miura. 1985. Purification of human urinary colony-stimulating factor by higher performance liquid chromatography. J. Chromatogr. 344:339-344.
11. Herrmann, J. L., N. Dubois, M. Fourgeaud, D. Basset, and P. H. Lagrange. 1994. Synergic inhibitory activity of amphotericin-B and γ interferon against intracellular Cryptococcus neoformans in murine macrophage. J. Antimicrob. Chemother. 34:1051-1058.
12. Hume, D. A., P. Pavli, R. E. Donahue, and I. J. Fidler. 1988. The effect of human recombinant macrophage colony-stimulating factor (CSF-1) on the murine mononuclear phagocyte system in vivo. J. Immunol. 141:3405-3409.
13. Ishizaka, Y., K. Motoyoshi, K. Hatake, M. Saito, F. Takaku, and Y. Miura. 1986. Mode of action of human urinary colony-stimulating factor. Exp. Hematol. 14:1-8.
14. Karbassi, A., J. M. Becker, J. S. Foster, and R. N. Moore. 1987. Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors. J. Immunol. 139:417-421.
15. Kullberg, B. J., J. W. Van't Wout, R. J. M. Poell, and R. Van Furth. 1992. Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. Antimicrob. Agents Chemother. 36:1225-1229.
16. Legrand, P., A. Vertut-Doi, and J. Bolard. 1996. Comparative internalization and recycling of different amphotericin B formulations by a macrophage-like cell line. J. Antimicrob. Chemother. 37:519-533.
17. Louie, A., A. L. Baltch, M. A. Franke, R. P. Smith, and M. A. Gordon. 1994. Comparative capacity of antifungal agents to stimulate murine macrophages to produce tumor necrosis factor alpha: an effect that is attenuated by pentoxifylline, liposomal vesicles, and dexamethasone. J. Antimicrob. Chemother. 34:975-987.
18. Metcalf, D. 1986. The molecular biology and function of the granulocyte-macrophage colony-stimulating factor. Blood 67:257-267.
19. Motoyoshi, K., T. Suda, K. Kusumoto, F. Takaku, and Y. Miura. 1982. Granulocyte-macrophage colony-stimulating and binding activities of purified human urinary colony-stimulating factor to murine and human bone marrow cells. Blood 60:1378-1386.
20. Motoyoshi, K., K. Yoshida, K. Hatake, M. Saito, Y. Miura, N. Yanai, M. Yamada, T. Kawashima, G. G. Wong, P. A. Temple, A. C. Leary, J. S. Witek-Giannoti, M. Fujisawa, A. Yuo, T. Okabe, and F. Takaku. 1989. Recombinant and native human urinary colony-stimulating factor directly augments granulocytic and granulocyte-macrophage colony-stimulating factor production of human peripheral blood monocytes. Exp. Hematol. 17:68-71.
21. Nassar, F., E. Brummer, and D. A. Stevens. 1994. Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans. Antimicrob. Agents Chemother. 38:2162-2164.
22. Nassar, F., E. Brummer, and D. A. Stevens. 1995. Macrophage colony-stimulating factor (M-CSF) induction of enhanced anticryptococcal activity in human monocyte-derived macrophages: synergy with fluconazole for killing. Cell. Immunol. 164:113-118.
23. Nemunaitis, J., J. D. Meyers, C. D. Buckner, K. Shannon-Dorcy, M. Mori, H. Shulman, J. A. Bianco, C. S. Higano, E. Groves, R. Storb, J. Hansen, F. R. Appelbaum, and J. W. Singer. 1991. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 78:907-913.
24. Nemunaitis, J., K. Shannon-Dorcy, F. R. Appelbaum, J. Meyers, A. Owens, R. Day, D. Ando, C. O'Neill, D. Buckner, and J. Singer. 1993. Long-term follow up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 82:1422-1427.
25. Pawelec, G., G. Ehninger, A. Rehbein, K. Schaudt, and K. Jaschonek. 1991. Comparison of the immunosuppressive activities of the anti-mycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells. Int. J. Immunopharmacol. 13:299-304.
26. Polak-Wyss, A. 1991. Protective effect of human granulocyte colony stimulating factor (hG-CSF) on Candida infections in normal and immunosuppressed mice. Mycoses 34:109-118.
27. Roilides, E., C. A. Lyman, S. D. Mertins, D. J. Cole, D. Venzon, P. A, Pizzo, S. J. Chanock, and T. J. Walsh. 1996. Ex vivo effects of macrophage colony stimulating factor on human monocyte activity against fungal and bacterial pathogens. Cytokine 8:42-48.
28. Roilides, E., T. Sein, A. Holmes, S. Chanock, C. Blake, P. A. Pizzo, and T. J. Walsh. 1995. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis. 172:1028-1034.
29. Sakurai, T., M. Yamada, S. Shimamura, and K. Motoyoshi. 1996. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction. Cell. Immunol. 171:87-94.
30. Ulich, T. R., J. del Castillo, L. R. Watson, S. Yin, and M. B. Garnich. 1990. In vivo hematologic effects of recombinant human macrophage colony-stimulating factor. Blood 75:846-850.
31. Vitt, C. R., J. M. Fidler, D. Ando, R. J. Zimmerman, and S. L. Aukerman. 1994. Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat. J. Infect. Dis. 169:369-374.
32. Warren, M. K., and P. Ralph. 1986. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J. Immunol. 137:2281-2285.
33. Wildfeuer, A., H. Laufen, and O. Haferkamp. 1990. Interaction of fluconazole and human phagocytic cells: uptake of the antifungal agent and its effects on the survival of ingested fungi in phagocytes. Arzneim.-Forsch./Drug.Res. 40:1044-1047.
34. Wolf, J. E., and S. E. Masoff. 1990. In vivo activation of macrophages oxidative burst activity by cytokines and amphotericin B. Infect. Immun. 58:1296-1300.
35. Wong, G. W., P. A. Temple, A. C. Leary, J. S. Witek-Giannotti, Y. C. Yang, A. B. Ciarletta, M. Chung, P. Murtha, R. Kiriz, R. J. Kaufman, C. R. Ferenz, B. S. Sibley, K. J. Turner, R. M. Hewick, S. C. Clark, N. Yanai, M. Yamada, M. Saito, K. Motoyoshi, and F. Takaku. 1987. Human CSF-1: molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science 235:1504-1508.
36. Yamaguchi, H., S. Abe, and Y. Tokuda. 1993. Immunomodulating activity of antifungal drugs. Ann. N. Y. Acad. Sci. 685:447-457.
37. Yamamoto, Y., K. Uchida, T. W. Klein, H. Friedman, and H. Yamaguchi. 1992. Immunomodulators and fungal infections: use of antifungal drugs in combination with G-CSF. p. 231-241. In H. Friedman (ed.), Microbial infections. Plenum Press, New York, N.Y.